Repligen withdraws SecreFlo MAA

Repligen Corp. (NASDAQ:RGEN) withdrew an MAA for SecreFlo to improve detection of pancreatic duct abnormalities in combination with MRI in patients with known or suspected pancreatitis. The company sa...